Q2 2024 · 13F-HR
Athyrium Capital Management, LPholdings as filed
Filed 2024-08-08 · accession 0001123292-24-000213
$33.5M
Reported value
3
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $22.2M | 66.3% | 30,000,000 | Common | NONE |
| 74319F305 | — | Biora Therapeutics Inc. | $7.2M | 21.5% | 10,929,762 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $4.1M | 12.2% | 1,256,411 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.